Bio-Rad is a global leader providing a broad array of clinical diagnostics and life science research products. With a team of more than 8,000 employees and a global network of operations serving our customers, we help people live longer, healthier lives.
Bio-Rad provides a wide range of products for use in the support of COVID-19 diagnostic screening, confirmation of test results, surveillance, and therapy/vaccine research and development. From molecular testing using real-time PCR or Droplet Digital PCR, to immunology assays, our wide range of solutions provide best in class sensitivity and accuracy.
Our products are used in research and clinical laboratories around the world, contributing to the advancement of COVID-19 research, SARS-CoV-2 screening assays, and vaccine development.
We are committed to providing reliable, sensitive solutions to help combat the global pandemic.
Bio-Rad was founded over six decades ago and has continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results.
Bio-Rad has a portfolio in excess of 11,000 antibodies and associated reagents, which are sold in over 55 countries world-wide, through both direct sales and via a network of global distributors. The portfolio business is complemented with a leading range of custom antibody manufacture and generation services, including recombinant monoclonal antibodies produced via HuCAL® technology.
The antibody business is head-quartered in Kidlington, near Oxford, England, along with its main production facilities.
Serve humanity, growth, innovation, stability, independence, opportunity
Connect with Bio-Rad AbD Serotec Ltd